Display options
Cite
ERRATA. Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2015;33(21):2412doi: 10.1200/JCO.2015.63.3990.
(2015). ERRATA. Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(21), 2412. https://doi.org/10.1200/JCO.2015.63.3990
"ERRATA. Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 33,21 (2015): 2412. doi: https://doi.org/10.1200/JCO.2015.63.3990
ERRATA. Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2015 Jul 20;33(21):2412. doi: 10.1200/JCO.2015.63.3990. PMID: 26184793; PMCID: PMC7008599.
Copy Download .nbib Format: NLM
Share it on

J Clin Oncol. 2015 Jul 20;33(21):2412. doi: 10.1200/JCO.2015.63.3990.

ERRATA. Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

[No authors listed]

PMID: 26184793 PMCID: PMC7008599 DOI: 10.1200/JCO.2015.63.3990

[No abstract available.]

Publication Types